Hyodeoxycholic acid

猪去氧胆酸

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameHyodeoxycholic acid
Drug Alias Name猪脱氧胆酸HDCAAHRO-001
ClassificationNatural product/ExtractSmall molecules > Steroids
Mechanisms of ActionCholesterol absorption inhibitorsGene expression stimulants
TargetsNot applicable
Therapy Area/IndicationsHyperlipidemiasAtherosclerosis
Global Approved IndicationsHyperlipidemias
Approved Indications in ChinaHyperlipidemias
Original Approved Country/TerritoryMainland China
Original Approved Date1982/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAtheronova Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesCardionovaAtheronova Inc
Active IndicationsHyperlipidemias
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeC10
Related LinksWikipediaDrugBank